R
Rosalie E. Ferner
Researcher at Guy's and St Thomas' NHS Foundation Trust
Publications - 100
Citations - 7597
Rosalie E. Ferner is an academic researcher from Guy's and St Thomas' NHS Foundation Trust. The author has contributed to research in topics: Neurofibromatosis & Neurofibroma. The author has an hindex of 37, co-authored 91 publications receiving 6570 citations. Previous affiliations of Rosalie E. Ferner include St Thomas' Hospital & King's College London.
Papers
More filters
Journal ArticleDOI
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Rosalie E. Ferner,Susan M Huson,Nicholas Thomas,Celia Moss,Harry Willshaw,D. Gareth Evans,Meena Upadhyaya,Richard Towers,Michael Gleeson,Christine Steiger,Amanda Kirby +10 more
TL;DR: A consensus statement on the current guidelines for diagnosis and management of neurofibromatosis 1 is produced, based on published clinical studies and on the pooled knowledge of experts with experience of providing multidisciplinary clinical and molecular services for NF1 patients.
Journal ArticleDOI
Neurofibromatosis type 1.
David H. Gutmann,Rosalie E. Ferner,Robert Listernick,Bruce R. Korf,Pamela L. Wolters,Kimberly J. Johnson +5 more
TL;DR: Although considerable progress has been made in understanding this condition, numerous challenges remain; a collaborative and interdisciplinary approach is required to manage individuals with neurofibromatosis type1 and to develop effective treatments.
Journal Article
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
TL;DR: A multidisciplinary team approach to the management of this complex disorder is advocated and collaborative research should be promoted with the aim of harnessing advances in molecular genetics to develop targeted therapies for MPNST in people with NF1.
Journal ArticleDOI
Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations
TL;DR: Advances in the understanding of the pathophysiology and clinical behavior of these tumors made over the last 10 years are highlighted and specific evidence‐based recommendations are proposed for clinicians caring for children with NF1.
Journal ArticleDOI
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective
TL;DR: The pertinent diagnostic, clinical, and genetic symptoms of NF1 and NF2 are discussed and the current views on the pathogenesis of these neurocutaneous disorders in the wake of advances in molecular genetics and the development of mouse models of disease are examined.